Researcher awarded $5 million by NHMRC for trial into post-surgery infection drug

Tranexamic acid (TXA) is used to reduce
 excessive bleeding. There is also evidence that
 TXA has immune-protective effects.

by Anne Crawford

Professor Paul Myles, Director of the Department of Anaesthesia and Perioperative Medicine in Central Clinical School and at The Alfred, has been awarded a $5.19 million Clinical Trials and Cohort Studies (CTCS) grant from the National Health and Medical Research Council (NHMRC) to conduct an international trial of a medication that could prevent infections after surgery.